Microalgae and Cyanobacteria As a Source of Glycosidase Inhibitors
Overview
Authors
Affiliations
Culture filtrates and organic solvent extracts of over 500 freshwater and marine eukaryotic microalgae and cyanobacteria were screened for the presence of glycosidase inhibitors. Rapid colorimetric assays were used to detect inhibitors of alpha-glucosidase, alpha-amylase and beta-galactosidase. Inhibitors were found from 38 species. The results suggest that microalgae and cyanobacteria have potential as a source of glycosidase inhibitors which may have clinical applications.
Revolutionizing Diabetes Care: The Role of Marine Bioactive Compounds and Microorganisms.
Reddy K, Rakesh K, Prathyusha S, Gupta J, Nagasree K, Lokeshvar R Cell Biochem Biophys. 2024; 83(1):193-213.
PMID: 39254792 DOI: 10.1007/s12013-024-01508-1.
Gradissimo D, Oliveira da Silva V, Xavier L, do Nascimento S, Borges da Silva Valadares R, Faustino S Microorganisms. 2021; 9(8).
PMID: 34442672 PMC: 8402191. DOI: 10.3390/microorganisms9081593.
Marine Organisms with Anti-Diabetes Properties.
Lauritano C, Ianora A Mar Drugs. 2016; 14(12).
PMID: 27916864 PMC: 5192457. DOI: 10.3390/md14120220.
Bioactive compound production by thermophilic and thermotolerant cyanobacteria (blue-green algae).
Fish S, Codd G World J Microbiol Biotechnol. 2014; 10(3):338-41.
PMID: 24421023 DOI: 10.1007/BF00414875.
Kim J Mycobiology. 2013; 34(3):138-42.
PMID: 24039487 PMC: 3769562. DOI: 10.4489/MYCO.2006.34.3.138.